Clinical trial
Randomized Clinical Comparison of Everolimus-Eluting SYNERGY® and Biolimus-Eluting BioMatrix NeoFlex® Coronary Stents in Non-Selected Patients With Ischemic Heart Disease
NCT02093845 is registered in ClinicalTrials.gov with Aarhus University Hospital Skejby as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Clinical Comparison of Everolimus-Eluting SYNERGY® and Biolimus-Eluting BioMatrix NeoFlex® Coronary Stents in Non-Selected Patients With Ischemic Heart Disease
- Lead sponsor
- Aarhus University Hospital Skejby
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- February 10, 2014
- Completion date
- December 31, 2020
- Enrollment
- 2,800 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
coronary artery disease, ischemic heart disease